More
    Guided Solutions - Connecting Talent With Innovation/div>

    GS MedTech Funding Tracker – GT Medical, Median Technologies and more

    We had a more quiet funding week, part of the expected summer downturn in investment activities. The biggest highlight was GT Medical, which closed funding to help them bring their innovative brain tumour treatment...

    GS MedTech Funding Tracker – GT Medical, Median Technologies and more

    We had a more quiet funding week, part of the expected summer downturn in investment activities. The biggest highlight was GT Medical, which closed...

    Varian launches microwave ablation system for soft tissue tumours in Europe

    Siemens Healthineers’ Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours. Tailored to offer predictability and control, the...

    FDA grants 510(k) clearance for Tempus AI’s ejection fraction software

    The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software. This software utilises AI to detect...

    Saluda launches next-gen sensing technology for neuromod

    Saluda Medical today announced the full launch of its EVA next-generation sensing technology for its neuromodulation therapy. Minneapolis-based Saluda develops the Evoke neuromodulation system. The...
    [hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

    Finance

    Funding

    Clinical Trials

    Xeltis reports positive EU trial results for Xabg coronary bypass conduit

    Xeltis, a leading developer of transformative implants that enable the natural creation of living and long-lasting vessels, today announces encouraging preliminary data for Xabg,...

    FDA approves Dymicron’s study of cervical artificial disc

    The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) approval for Dymicron to initiate a pivotal trial of its Triadyme-C...

    Radical Catheter Technologies’ catheter demonstrates positive performance

    Radical Catheter Technologies™, a pioneering medical device company and a NeuroTechnology Investors (NTI) portfolio company focused on advancing the next generation of endovascular access...

    PanTher Therapeutics launches second trial for chemotherapy patch

    US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable. The Phase Ib study (NCT06673017)...

    Innovation

    Regulatory Approvals

    GS MedTech Funding Tracker – GT Medical, Median Technologies and more

    We had a more quiet funding week, part of the expected summer downturn in investment activities. The biggest highlight was GT Medical, which closed...

    Varian launches microwave ablation system for soft tissue tumours in Europe

    Siemens Healthineers’ Varian has introduced the next-generation microwave ablation solution, IntelliBlate, in Europe to treat soft tissue tumours. Tailored to offer predictability and control, the...

    FDA grants 510(k) clearance for Tempus AI’s ejection fraction software

    The US Food and Drug Administration (FDA) has granted 510(k) clearance for Tempus AI’s ECG-Low (ejection fraction) EF software. This software utilises AI to detect...

    Saluda launches next-gen sensing technology for neuromod

    Saluda Medical today announced the full launch of its EVA next-generation sensing technology for its neuromodulation therapy. Minneapolis-based Saluda develops the Evoke neuromodulation system. The...

    M&A

    Archives

    Latest articles